ECM
CUE icon

ExodusPoint Capital Management’s Cue Biopharma CUE Stock Holding History

ExodusPoint Capital Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-555
Closed -$243K – 2226
2021
Q3 		$243K Sell
555
-294
-35% -$103K ﹤0.01% 1709
2021
Q2 		$297K Buy
849
+497
+141% +$193K ﹤0.01% 1747
2021
Q1 		$129K Buy
+352
New +$145K ﹤0.01% 1945
2020
Q3 		– Sell
-282
Closed -$208K – 1831
2020
Q2 		$208K Buy
+282
New +$204K 0.01% 1502

Other funds holding CUE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

ExodusPoint Capital Management's CUE Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of Cue Biopharma (CUE) in Q4 2021, closing a stake of 555 shares — an estimated $243K sold.

ExodusPoint Capital Management first reported a position in CUE in Q2 2020 and held it in 4 quarters. The position peaked at $297K in Q2 2021. 90 funds tracked by Wall St. Rank hold CUE as of Q4 2021.

  • ExodusPoint Capital Management reported no remaining Cue Biopharma position as of Q4 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 555 Cue Biopharma shares in Q4 2021, an estimated $243K.
  • ExodusPoint Capital Management first reported a position in Cue Biopharma in Q2 2020 and held it in 4 quarters.
  • ExodusPoint Capital Management's Cue Biopharma position peaked at $297K in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.